Pacific Biosciences of California's (PACB) Hold Rating Reaffirmed at Cantor Fitzgerald
5 May 2019
Finance Daily
Cantor Fitzgerald reiterated their hold rating on shares of Pacific Biosciences of California (NASDAQ:PACB) in a research report report published on Friday morning, AnalystRatings.com reports. Cantor Fitzgerald currently has a $8.00 price target on the"..